Madhukar S Patel1, Jahan Mohebali2, Jigesh A Shah3, James F Markmann4, Parsia A Vagefi5. 1. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mspatel1@partners.org. 2. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: mohebali.jahan@mgh.harvard.edu. 3. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: jashah@partners.org. 4. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: jmarkmann@partners.org. 5. Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. Electronic address: pvagefi@mgh.harvard.edu.
Abstract
BACKGROUND: Liver transplant (LT) patients are at high risk for readmission. This study sought to identify predictors of readmission following liver transplantation and to evaluate their impact on survival in a region with prolonged waiting list times. METHODS: A single center review of adult deceased donor LT's from 2005 to 2015 was performed, with linkage to the UNOS Standard Transplant Analysis and Research registry. Readmission was defined as hospitalization within 90 days of discharge. Logistic regression was used to identify independent predictors of readmission and Kaplan-Meier analysis for survival. RESULTS: 325 patients underwent LT with an overall 90-day readmission rate of 46%. Upon adjusted analysis, predictors of readmission were age (OR 0.97 per year), male gender (OR 0.48), hospital length of stay (OR 1.03 per day), and hepatitis C liver failure (OR 2.37). Readmitted patients demonstrated a significantly lower 5-year survival (75% vs. 88%, p = 0.008) with only one patient (0.7%) dying during initial readmission. CONCLUSIONS: Nearly half of all patients are readmitted after LT. As readmission portents decreased survival, an emphasis should be placed on identifying and optimizing those at increased risk. If readmission does occur, however, it presents an opportunity to intervene, as virtually no patients died during initial readmission.
BACKGROUND: Liver transplant (LT) patients are at high risk for readmission. This study sought to identify predictors of readmission following liver transplantation and to evaluate their impact on survival in a region with prolonged waiting list times. METHODS: A single center review of adult deceased donor LT's from 2005 to 2015 was performed, with linkage to the UNOS Standard Transplant Analysis and Research registry. Readmission was defined as hospitalization within 90 days of discharge. Logistic regression was used to identify independent predictors of readmission and Kaplan-Meier analysis for survival. RESULTS: 325 patients underwent LT with an overall 90-day readmission rate of 46%. Upon adjusted analysis, predictors of readmission were age (OR 0.97 per year), male gender (OR 0.48), hospital length of stay (OR 1.03 per day), and hepatitis C liver failure (OR 2.37). Readmitted patients demonstrated a significantly lower 5-year survival (75% vs. 88%, p = 0.008) with only one patient (0.7%) dying during initial readmission. CONCLUSIONS: Nearly half of all patients are readmitted after LT. As readmission portents decreased survival, an emphasis should be placed on identifying and optimizing those at increased risk. If readmission does occur, however, it presents an opportunity to intervene, as virtually no patients died during initial readmission.
Authors: Greg D Sacks; Aaron J Dawes; Marcia M Russell; Anne Y Lin; Melinda Maggard-Gibbons; Deborah Winograd; Hallie R Chung; James Tomlinson; Areti Tillou; Stephen B Shew; Darryl T Hiyama; H Gill Cryer; F Charles Brunicardi; Jonathan R Hiatt; Clifford Ko Journal: JAMA Surg Date: 2014-08 Impact factor: 14.766
Authors: Flavio Paterno; Gregory C Wilson; Koffi Wima; Ralph C Quillin; Daniel E Abbott; Madison C Cuffy; Tayyab S Diwan; Tiffany Kaiser; E Steve Woodle; Shimul A Shah Journal: Surgery Date: 2014-10 Impact factor: 3.982
Authors: Gregory C Wilson; Richard S Hoehn; Audrey E Ertel; Koffi Wima; R Cutler Quillin; Sam Hohmann; Flavio Paterno; Daniel E Abbott; Shimul A Shah Journal: Liver Transpl Date: 2015-07 Impact factor: 5.799
Authors: Kumar Dharmarajan; Angela F Hsieh; Zhenqiu Lin; Héctor Bueno; Joseph S Ross; Leora I Horwitz; José Augusto Barreto-Filho; Nancy Kim; Susannah M Bernheim; Lisa G Suter; Elizabeth E Drye; Harlan M Krumholz Journal: JAMA Date: 2013-01-23 Impact factor: 56.272
Authors: Barbara M Murphy; Peter C Elliott; Michael R Le Grande; Rosemary O Higgins; Christine S Ernest; Alan J Goble; James Tatoulis; Marian U C Worcester Journal: Eur J Cardiovasc Prev Rehabil Date: 2008-04
Authors: Manar Salah; Iman Fawzy Montasser; Hanaa A El Gendy; Alaa A Korraa; Gamal M Elewa; Hany Dabbous; Hossam R Mahfouz; Mostafa Abdelrahman; Mohammed Hisham Goda; Mohamed Mohamed Bahaa El-Din; Mahmoud El-Meteini; Heba A Labib Journal: World J Hepatol Date: 2022-06-27
Authors: Lindsay A Sobotka; Rohan M Modi; Akshay Vijayaraman; A James Hanje; Anthony J Michaels; Lanla F Conteh; Alice Hinton; Ashraf El-Hinnawi; Khalid Mumtaz Journal: World J Hepatol Date: 2018-06-27
Authors: Khalid Mumtaz; Jannel Lee-Allen; Kyle Porter; Sean Kelly; James Hanje; Lanla F Conteh; Anthony J Michaels; Ashraf El-Hinnawi; Ken Washburn; Sylvester M Black; Marwan S Abougergi Journal: Sci Rep Date: 2020-11-06 Impact factor: 4.379
Authors: Gonzalo P Rodríguez-Laiz; Paola Melgar-Requena; Cándido F Alcázar-López; Mariano Franco-Campello; Celia Villodre-Tudela; Sonia Pascual-Bartolomé; Pablo Bellot-García; María Rodríguez-Soler; Cayetano F Miralles-Maciá; Patricio Más-Serrano; José A Navarro-Martínez; Francisco J Martínez-Adsuar; Luis Gómez-Salinas; Francisco A Jaime-Sánchez; Miguel Perdiguero-Gil; María Díaz-Cuevas; José M Palazón-Azorín; José Such-Ronda; Félix Lluís-Casajuana; José M Ramia-Ángel Journal: World J Surg Date: 2021-02-23 Impact factor: 3.352